
Coeliac Disease Study Pukekohe 102-1
Pukekohe Auckland
Help support research aimed at advancing treatments for yourself and others living with coeliac disease.
Please note that this study has now closed. However, we encourage you to pre-register your interest for future coeliac disease studies here.
Description
What to expect
Ages
Adults 18+ years old
Duration
Varies
Compensation
Participants are well paid for time and study-related expenses.
Eligibility Criteria
You may be eligible to take part if you:
Locations
Coeliac Disease is an autoimmune disorder that develops in genetically predisposed people. It involves an immune response to gluten containing foods such as wheat, barley and rye found in bread, cereals, pasta and baked goods.
The only current treatment is to maintain a lifelong strict gluten free diet which can be extremely challenging and near impossible. The inevitable breaks in the diet result in uncomfortable symptoms such as diarrhoea, abdominal pain and bloating that disrupt everyday life. On top of this, availability of gluten free food varies between countries and regions and the cost is significantly higher than equivalent gluten containing food.
As such, there is significant unmet medical need for safe and effective alternative treatments in addition to dietary avoidance of gluten.
This research study will look at the effects of an investigational study treatment on Coeliac Disease and selected biomarkers during and following a 16-day gluten challenge.
The study will involve an intravenous infusion of the investigational treatment or a placebo (a medication with no active ingredients) once a week for four weeks. Participants will also complete gluten challenge by consuming a provided amount of gluten.
Register your interest now to find out if you are eligible to participate in this study and help develop potential new treatment options for people living with coeliac disease.
This study is now closed
Please note that this study has now closed. However, we encourage you to pre-register your interest for future coeliac disease studies here.